CART-19 Cells for R/R B-cell Lymphoma
Condition(s):Relapsed or Refractory B-cell LymphomaLast Updated:January 5, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Relapsed or Refractory B-cell LymphomaLast Updated:January 5, 2018Unknown status
Condition(s):Refractory Large B-cell LymphomaLast Updated:February 20, 2024Completed
Condition(s):Diffuse Large B-cell LymphomaLast Updated:December 19, 2023Active, not recruiting
Condition(s):Relapsed/Refractory Large B-cell LymphomaLast Updated:March 13, 2024Recruiting
Condition(s):Diffuse Large B-cell LymphomaLast Updated:April 18, 2016Completed
Condition(s):B-Cell Non-Hodgkin LymphomaLast Updated:March 20, 2024Active, not recruiting
Condition(s):B Cell LymphomaLast Updated:August 23, 2018Completed
Condition(s):Relapsed/Refractory B-cell Non-Hodgkin’s LymphomaLast Updated:February 9, 2023Unknown status
Condition(s):Lymphoma, Large-Cell, Diffuse; Lymphoma, B-Cell RefractoryLast Updated:September 4, 2015Terminated
Condition(s):Primary Mediastinal Large B-cell Lymphoma (PMBCL)Last Updated:September 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.